CNS Metastases

8 registered clinical trials studyying CNS Metastases — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342	Reveal Pharmaceuticals Inc.	Phase 2
Recruiting	Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma NCT06552559	Samsung Medical Center	Phase 1 / Phase 2
Recruiting	A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871	Iambic Therapeutics, Inc	Phase 1
Recruiting	An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis NCT06352502	Tang-Du Hospital	—
Recruiting	A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours NCT04109131	Jules Bordet Institute	N/A
Terminated	131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases NCT03275402	Y-mAbs Therapeutics	Phase 2 / Phase 3
Withdrawn	Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls NCT01312506	University of Pittsburgh	—
Terminated	Electrochemotherapy as a Palliative Treatment for Brain Metastases NCT01322100	Copenhagen University Hospital at Herlev	Phase 1